Takeda Pharmaceutical Company Limited is a global, research-driven biopharmaceutical company headquartered in Tokyo, Japan. Founded in 1781, it discovers, develops, manufactures, and commercializes medicines for patients worldwide.
Takeda focuses on oncology, gastroenterology, neuroscience, and rare diseases, and also has activities in vaccines and plasma-derived therapies. Its portfolio spans small molecules and biologics, with capabilities from active pharmaceutical ingredient (API) production to finished dosage forms, including solid oral, injectable, and specialty products.
The company operates R&D hubs and GMP manufacturing sites across Japan, Europe, and the Americas, supplying healthcare markets through an integrated global network. Takeda emphasizes quality, compliance, and sustainability across its operations and supply chain.